Overview
Pulmonary interstitial glycogenosis (PIG) is a rare genetic disorder characterized by the accumulation of glycogen in the interstitial cells of the lungs, often presenting in infancy with respiratory distress. 1Diagnosis
Clinical Presentation: Neonatal respiratory distress, hypoxemia 1
Diagnostic Tests:
- Lung biopsy essential for definitive diagnosis, revealing characteristic glycogen accumulation 1
- Echocardiography to assess for associated cardiac abnormalities like hypertrophic cardiomyopathy 1
Differential Diagnosis: Includes other interstitial lung diseases and congenital heart defects 1Management
Supportive Care: Oxygen therapy, mechanical ventilation as needed 1
Cardiac Management: Specific treatment for hypertrophic cardiomyopathy may be required, tailored to clinical presentation 1
No Specific Pharmacological Treatment: Current evidence lacks definitive pharmacological interventions beyond supportive care 1Special Populations
Pediatrics: PIG predominantly affects neonates and infants, with severe outcomes possible in complex presentations involving pulmonary hypertension and cardiomyopathy 1
Comorbidities: Association with pulmonary hypertension and hypertrophic cardiomyopathy highlights the need for multidisciplinary management 1Key Recommendations
Lung biopsy is crucial for confirming the diagnosis of PIG, especially in cases of unexplained neonatal pulmonary hypertension [Evidence: Strong] 1
Comprehensive cardiac evaluation, including echocardiography, is recommended to identify associated cardiac conditions like hypertrophic cardiomyopathy [Evidence: Moderate] 1
Management should focus on supportive care measures tailored to respiratory and cardiac needs, with close monitoring for complications [Evidence: Expert opinion] 1References
1 Alkhorayyef A, Ryerson L, Chan A, Phillipos E, Lacson A, Adatia I. Pulmonary interstitial glycogenosis associated with pulmonary hypertension and hypertrophic cardiomyopathy. Pediatric cardiology 2013. link